Amplio Pharma
Company

Amplio Pharma

Pharmaceutical Manufacturing Lb, Nl 7 employees
Employees
7
Contacts
3
Emails
3

Amplio Pharma Overview

Headquarters
Lb, Nl
Industry
Pharmaceutical Manufacturing
Employees
7
Founded
2020
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing

About Amplio Pharma

Amplio Pharma is a novel and exciting product company developing improved versions of already great drugs. Amplio Pharma is a privately owned wholly women founded pharmaceutical company. Our vision is to develop and apply modern-day technology to fix the short-comings from drugs that otherwise have a proven track record in their disease area. Our first development candidate, Methotrexate Forte (AMP101), is being developed to boost the responder rate to current 1st line RA treatment from ca 35% to up to 70%. We reach this goal through inverse retention, where we maintain the active form of the 1st line treatment of choice - injectable low-dose Methotrexate - in the body for a longer period of time.

Amplio Pharma Contact Details

People in AeroLeads
4
With contact data
3
Email contacts
3
75.0% coverage

Amplio Pharma Org Chart

Sample employees and titles
Name Title Contact
Curtis Sprouse Building World-class Leaders and Teams
View
Marc Roelofs Investment Manager @ Uva Amc Hva
Email
Henrik Fenger Vice President - Int. Marketing, Sales
Email
Rob Mayfield Investing in Life Science and Health
Email

Employees by Management Level

Individual contributor 2 profiles
Executive 1 profile
Manager 1 profile

Compare Similar Companies to Amplio Pharma